![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SF3A3 |
Gene summary for SF3A3 |
![]() |
Gene information | Species | Human | Gene symbol | SF3A3 | Gene ID | 10946 |
Gene name | splicing factor 3a subunit 3 | |
Gene Alias | PRP9 | |
Cytomap | 1p34.3 | |
Gene Type | protein-coding | GO ID | GO:0000245 | UniProtAcc | B4DW90 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10946 | SF3A3 | LZE4T | Human | Esophagus | ESCC | 1.63e-13 | 2.53e-01 | 0.0811 |
10946 | SF3A3 | LZE7T | Human | Esophagus | ESCC | 5.08e-08 | 6.23e-01 | 0.0667 |
10946 | SF3A3 | LZE8T | Human | Esophagus | ESCC | 5.08e-08 | 1.70e-01 | 0.067 |
10946 | SF3A3 | LZE22D1 | Human | Esophagus | HGIN | 2.98e-04 | -5.51e-03 | 0.0595 |
10946 | SF3A3 | LZE22T | Human | Esophagus | ESCC | 2.78e-07 | 3.27e-01 | 0.068 |
10946 | SF3A3 | LZE24D1 | Human | Esophagus | HGIN | 7.05e-03 | 2.98e-01 | 0.054 |
10946 | SF3A3 | LZE24T | Human | Esophagus | ESCC | 1.28e-18 | 4.67e-01 | 0.0596 |
10946 | SF3A3 | LZE21T | Human | Esophagus | ESCC | 1.32e-04 | 2.62e-01 | 0.0655 |
10946 | SF3A3 | LZE6T | Human | Esophagus | ESCC | 6.49e-05 | 2.09e-01 | 0.0845 |
10946 | SF3A3 | P1T-E | Human | Esophagus | ESCC | 2.63e-04 | 2.92e-01 | 0.0875 |
10946 | SF3A3 | P2T-E | Human | Esophagus | ESCC | 2.03e-53 | 9.42e-01 | 0.1177 |
10946 | SF3A3 | P4T-E | Human | Esophagus | ESCC | 3.26e-29 | 7.47e-01 | 0.1323 |
10946 | SF3A3 | P5T-E | Human | Esophagus | ESCC | 3.38e-20 | 5.99e-01 | 0.1327 |
10946 | SF3A3 | P8T-E | Human | Esophagus | ESCC | 2.82e-25 | 4.86e-01 | 0.0889 |
10946 | SF3A3 | P9T-E | Human | Esophagus | ESCC | 9.21e-15 | 3.13e-01 | 0.1131 |
10946 | SF3A3 | P10T-E | Human | Esophagus | ESCC | 2.37e-42 | 8.78e-01 | 0.116 |
10946 | SF3A3 | P11T-E | Human | Esophagus | ESCC | 5.82e-24 | 7.87e-01 | 0.1426 |
10946 | SF3A3 | P12T-E | Human | Esophagus | ESCC | 5.48e-25 | 5.54e-01 | 0.1122 |
10946 | SF3A3 | P15T-E | Human | Esophagus | ESCC | 2.37e-26 | 6.99e-01 | 0.1149 |
10946 | SF3A3 | P16T-E | Human | Esophagus | ESCC | 3.45e-32 | 5.32e-01 | 0.1153 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000838034 | Thyroid | ATC | RNA splicing | 270/6293 | 434/18723 | 7.50e-35 | 1.19e-31 | 270 |
GO:000037534 | Thyroid | ATC | RNA splicing, via transesterification reactions | 200/6293 | 324/18723 | 1.75e-25 | 7.39e-23 | 200 |
GO:000037734 | Thyroid | ATC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 197/6293 | 320/18723 | 6.54e-25 | 2.18e-22 | 197 |
GO:000039834 | Thyroid | ATC | mRNA splicing, via spliceosome | 197/6293 | 320/18723 | 6.54e-25 | 2.18e-22 | 197 |
GO:007182635 | Thyroid | ATC | ribonucleoprotein complex subunit organization | 133/6293 | 227/18723 | 8.32e-15 | 5.01e-13 | 133 |
GO:002261835 | Thyroid | ATC | ribonucleoprotein complex assembly | 129/6293 | 220/18723 | 1.93e-14 | 1.10e-12 | 129 |
GO:000024515 | Thyroid | ATC | spliceosomal complex assembly | 38/6293 | 79/18723 | 5.28e-03 | 2.15e-02 | 38 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0304018 | Esophagus | HGIN | Spliceosome | 79/1383 | 217/8465 | 3.22e-13 | 7.00e-12 | 5.56e-12 | 79 |
hsa0304019 | Esophagus | HGIN | Spliceosome | 79/1383 | 217/8465 | 3.22e-13 | 7.00e-12 | 5.56e-12 | 79 |
hsa0304027 | Esophagus | ESCC | Spliceosome | 128/4205 | 217/8465 | 3.31e-03 | 8.79e-03 | 4.50e-03 | 128 |
hsa0304037 | Esophagus | ESCC | Spliceosome | 128/4205 | 217/8465 | 3.31e-03 | 8.79e-03 | 4.50e-03 | 128 |
hsa030407 | Liver | Cirrhotic | Spliceosome | 102/2530 | 217/8465 | 5.69e-08 | 9.47e-07 | 5.84e-07 | 102 |
hsa0304012 | Liver | Cirrhotic | Spliceosome | 102/2530 | 217/8465 | 5.69e-08 | 9.47e-07 | 5.84e-07 | 102 |
hsa0304022 | Liver | HCC | Spliceosome | 122/4020 | 217/8465 | 5.55e-03 | 1.60e-02 | 8.91e-03 | 122 |
hsa0304032 | Liver | HCC | Spliceosome | 122/4020 | 217/8465 | 5.55e-03 | 1.60e-02 | 8.91e-03 | 122 |
hsa0304016 | Oral cavity | OSCC | Spliceosome | 123/3704 | 217/8465 | 7.21e-05 | 2.74e-04 | 1.40e-04 | 123 |
hsa0304017 | Oral cavity | OSCC | Spliceosome | 123/3704 | 217/8465 | 7.21e-05 | 2.74e-04 | 1.40e-04 | 123 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SF3A3 | SNV | Missense_Mutation | novel | c.260N>C | p.Arg87Thr | p.R87T | Q12874 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-3C-AALI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Poly E | Complete Response |
SF3A3 | SNV | Missense_Mutation | c.644N>T | p.Ala215Val | p.A215V | Q12874 | protein_coding | tolerated(0.18) | benign(0) | TCGA-BH-A0HF-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | |
SF3A3 | insertion | Frame_Shift_Ins | novel | c.751_752insTAATGGAACTTATGGTCATATGGGAAAAACAGACAAATAAG | p.Ser251LeufsTer27 | p.S251Lfs*27 | Q12874 | protein_coding | TCGA-C8-A1HE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
SF3A3 | deletion | Frame_Shift_Del | novel | c.693delA | p.Glu232ArgfsTer6 | p.E232Rfs*6 | Q12874 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
SF3A3 | deletion | Frame_Shift_Del | novel | c.1308delG | p.Arg436SerfsTer14 | p.R436Sfs*14 | Q12874 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
SF3A3 | SNV | Missense_Mutation | novel | c.184N>A | p.Asp62Asn | p.D62N | Q12874 | protein_coding | tolerated(0.1) | benign(0.035) | TCGA-C5-A2LY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
SF3A3 | SNV | Missense_Mutation | novel | c.6G>C | p.Glu2Asp | p.E2D | Q12874 | protein_coding | tolerated(0.3) | probably_damaging(0.956) | TCGA-C5-A3HF-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
SF3A3 | SNV | Missense_Mutation | c.816N>C | p.Leu272Phe | p.L272F | Q12874 | protein_coding | deleterious(0) | possibly_damaging(0.783) | TCGA-JX-A3Q0-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD | |
SF3A3 | SNV | Missense_Mutation | novel | c.646N>A | p.Glu216Lys | p.E216K | Q12874 | protein_coding | tolerated(0.08) | benign(0.01) | TCGA-JX-A3Q0-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD |
SF3A3 | SNV | Missense_Mutation | novel | c.142N>A | p.Asp48Asn | p.D48N | Q12874 | protein_coding | deleterious(0.03) | benign(0.226) | TCGA-ZJ-AAXT-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |